Etodolac

Generic name: Pronounced as (ee toe doe' lak)
Brand names
  • Lodine®
  • Lodine® XL
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2021

People who take nonsteroidal anti-inflammatory drugs (NSAIDs) (other than aspirin) such as etodolac may have a higher risk of having a heart attack or a stroke than people who do not take these medications. These events may happen without warning and may cause death. This risk may be higher for people who take NSAIDs for a long time. Do not take an NSAID such as etodolac if you have recently had a heart attack, unless directed to do so by your doctor. Tell your doctor if you or anyone in your family has or has ever had heart disease, a heart attack, or a stroke, if you smoke, and if you have or have ever had high cholesterol, high blood pressure, or diabetes. Get emergency medical help right away if you experience any of the following symptoms: chest pain, shortness of breath, weakness in one part or side of the body, or slurred speech.

If you will be undergoing a coronary artery bypass graft (CABG; a type of heart surgery), you should not take etodolac right before or right after the surgery.

NSAIDs such as etodolac may cause ulcers, bleeding, or holes in the stomach or intestine. These problems may develop at any time during treatment, may happen without warning symptoms, and may cause death. The risk may be higher for people who take NSAIDs for a long time, are older in age, have poor health, or drink large amounts of alcohol while you are taking etodolac. Tell your doctor if you take any of the following medications: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); aspirin; other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); oral steroids such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos); selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), fluoxetine (Prozac, Sarafem, Selfemra, in Symbyax), fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); or serotonin norepinephrine reuptake inhibitors (SNRIs) such as desvenlafaxine (Khedezla, Pristiq), duloxetine (Cymbalta), and venlafaxine (Effexor XR). Also tell your doctor if you have or have ever had ulcers or bleeding in your stomach or intestines or other bleeding disorders. If you experience any of the following symptoms, stop taking etodolac and call your doctor: stomach pain, heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, or black and tarry stools.

Keep all appointments with your doctor and the laboratory. Your doctor will monitor your symptoms carefully and will probably order certain tests to check your body's response to etodolac. Be sure to tell your doctor how you are feeling so that your doctor can prescribe the right amount of medication to treat your condition with the lowest risk of serious side effects.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with etodolac and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/drugs/drugsafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Etodolac tablets, capsules, and extended-release (long-acting) tablets are used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). Etodolac tablets and capsules are also used to relieve pain from other causes. Etodolac is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.

Etodolac comes as a tablet, a capsule, and an extended-release tablet to take by mouth. To treat arthritis, the tablet and capsule are usually taken two to three times a day and the extended-release tablet is usually taken once a day. To relieve pain from other causes, the tablets and capsules are usually taken every 6 to 8 hours. Take etodolac at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take etodolac exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release tablets whole; do not split, chew, or crush them.

If you are taking etodolac for arthritis, your doctor may start you on a high dose and decrease your dose once your symptoms are controlled. It may take 1 to 2 weeks for you to feel the full benefit of this medication.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking etodolac,

  • tell your doctor and pharmacist if you are allergic to etodolac, aspirin or other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn), any other medications, or any of the inactive ingredients in etodolac tablets, capsules, or extended-release tablets. Ask your pharmacist for a list of inactive ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril, enalapril (Vasotec, in Vaseretic), fosinopril, lisinopril (in Zestoretic), moexipril (Univasc), perindopril (Aceon, in Prestalia), quinapril (Accupril, in Quinaretic), ramipril (Altace), and trandolapril (Mavik, in Tarka); angiotensin receptor blockers such as candesartan (Atacand, in Atacand HCT), eprosartan (Teveten), irbesartan (Avapro, in Avalide), losartan (Cozaar, in Hyzaar), olmesartan (Benicar, in Azor, in Benicar HCT, in Tribenzor), telmisartan (Micardis, in Micardis HCT, in Twynsta), and valsartan (in Exforge HCT); cyclosporine (Gengraf, Neoral, Sandimmune); digoxin (Lanoxin); diuretics ('water pills'); lithium (Lithobid); and methotrexate (Otrexup, Rasuvo, Trexall). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma, especially if you also have frequent stuffed or runny nose or nasal polyps (swelling of the lining of the nose); heart failure; swelling of the hands, feet, ankles, or lower legs; or kidney or liver disease.

  • tell your doctor if you are pregnant, especially if you are around 20 weeks or later pregnant, you plan to become pregnant, or if you are breastfeeding. If you become pregnant while taking etodolac, call your doctor. Etodolac may harm the fetus and cause problems with delivery if it is taken around 20 weeks or later during pregnancy. Do not take etodolac around or after 20 weeks of pregnancy, unless you are told to do so by your doctor.

  • talk to your doctor about the risks and benefits of taking etodolac if you are 75 years of age or older. Do not take this medication for a longer period of time or at a higher dose than recommended by your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking etodolac.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Etodolac may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • constipation

    • diarrhea

    • gas or bloating

    • vomiting

    • headache

    • dizziness

    • ringing in the ears

    • runny nose

    • sore throat

    • blurred vision

  • Some side effects can be serious. If you experience any of the following symptoms, or those mentioned in the IMPORTANT WARNING section, call your doctor immediately. Do not take any more etodolac until you speak to your doctor.

    • unexplained weight gain

    • shortness of breath or difficulty breathing

    • swelling of the abdomen, feet, ankles, or lower legs

    • swelling of the eyes, face, lips, tongue, throat, or hands

    • fever or chills

    • blisters

    • rash

    • itching

    • hives

    • hoarseness

    • difficulty swallowing

    • yellowing of the skin or eyes

    • excessive tiredness

    • unusual bleeding or bruising

    • lack of energy

    • loss of appetite

    • pain in the upper right part of the stomach

    • flu-like symptoms

    • pale skin

    • fast heartbeat

    • cloudy, discolored, or bloody urine

    • difficult or painful urination

    • back pain

  • Etodolac may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Do not prepare doses of etodolac tablets in advance; keep the tablets in the original container until you are ready to take them. Store etodolac at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • lack of energy

  • drowsiness

  • nausea

  • vomiting

  • stomach pain

  • bloody, black or tarry stool

  • vomit that is bloody or looks like coffee grounds

  • coma (loss of consciousness for a period of time)

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking etodolac.

If you have diabetes and you test your urine for ketones, you should know that etodolac may interfere with the results of this type of test. Talk to your doctor about how you should monitor your diabetes while you are taking etodolac.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin Etodolac may increase the neuroexcitatory activities of Moxifloxacin.
Montelukast Montelukast The metabolism of Etodolac can be decreased when combined with Montelukast.
Leflunomide Leflunomide The metabolism of Etodolac can be decreased when combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Etodolac can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Etodolac can be decreased when combined with Nevirapine.
Alendronate Alendronate The risk or severity of adverse effects can be increased when Etodolac is combined with Alendronic acid.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Etodolac is combined with Anagrelide.
Candesartan Candesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Etodolac.
Cilostazol Cilostazol The risk or severity of bleeding can be increased when Etodolac is combined with Cilostazol.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Etodolac is combined with Clopidogrel.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Etodolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate Etodolac may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Etodolac.
Magnesium Hydroxide Magnesium Hydroxide Etodolac may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Etodolac.
Mycophenolate Mycophenolate Etodolac may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of hypertension can be increased when Etodolac is combined with Naratriptan.
Olsalazine Olsalazine The therapeutic efficacy of Olsalazine can be decreased when used in combination with Etodolac.
Penbutolol Penbutolol Etodolac may decrease the antihypertensive activities of Acebutolol.
Potassium Potassium Etodolac may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The risk or severity of gastrointestinal irritation can be increased when Etodolac is combined with Prednisone.
Ranitidine Ranitidine Etodolac may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The therapeutic efficacy of Reserpine can be decreased when used in combination with Etodolac.
Rizatriptan Rizatriptan Etodolac may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Etodolac may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The risk or severity of renal failure can be increased when Etodolac is combined with Tacrolimus.
Tiludronate Tiludronate The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Etidronic acid.
Triamcinolone Triamcinolone The risk or severity of gastrointestinal irritation can be increased when Triamcinolone is combined with Etodolac.
Zolmitriptan Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Etodolac.
Ampicillin Injection Ampicillin Injection Etodolac may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Etodolac may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection The metabolism of Etodolac can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Etodolac is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Etodolac may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Etodolac may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Etodolac may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Etodolac.
Metoclopramide Injection Metoclopramide Injection Etodolac may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Metronidazole Injection Metronidazole Injection The metabolism of Etodolac can be decreased when combined with Metronidazole.
Pamidronate Injection Pamidronate Injection The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Etodolac may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of bleeding can be increased when Zidovudine is combined with Etodolac.
Altretamine Altretamine Etodolac may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Etodolac which could result in a higher serum level.
Cyclosporine Cyclosporine The risk or severity of renal failure and hypertension can be increased when Etodolac is combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Etodolac.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Enoxaparin.
Torsemide Torsemide The therapeutic efficacy of Torasemide can be decreased when used in combination with Etodolac.
Olanzapine Olanzapine The metabolism of Etodolac can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Etodolac.
Eprosartan Eprosartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Etodolac.
Meloxicam Meloxicam The risk or severity of adverse effects can be increased when Etodolac is combined with Meloxicam.
Pantoprazole Pantoprazole Etodolac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Risedronic acid.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Etodolac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Etodolac.
Temozolomide Temozolomide Etodolac may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Etodolac may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Etodolac can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Etodolac.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Pentosan polysulfate.
Trimipramine Trimipramine The metabolism of Etodolac can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Etodolac can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Etodolac can be decreased when combined with Modafinil.
Perindopril Perindopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Perindopril.
Tenofovir Tenofovir Etodolac may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of adverse effects can be increased when Etodolac is combined with Choline magnesium trisalicylate.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Etodolac is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Etodolac can be decreased when combined with Epinephrine.
Eplerenone Eplerenone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Eplerenone.
Escitalopram Escitalopram The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Etodolac.
Olmesartan Olmesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Etodolac.
Zonisamide Zonisamide Etodolac may decrease the excretion rate of Zonisamide which could result in a higher serum level.
Adalimumab Injection Adalimumab Injection The metabolism of Etodolac can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypertension can be increased when Etodolac is combined with Aripiprazole.
Atomoxetine Atomoxetine Etodolac may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Dexmethylphenidate Dexmethylphenidate The risk or severity of hypertension can be increased when Etodolac is combined with Dexmethylphenidate.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Etodolac which could result in a higher serum level.
Almotriptan Almotriptan Etodolac may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan The metabolism of Etodolac can be decreased when combined with Eletriptan.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Etodolac.
Aprepitant Aprepitant The metabolism of Etodolac can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Etodolac may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Etodolac may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Etodolac may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The risk or severity of hypertension can be increased when Etodolac is combined with Frovatriptan.
Gemifloxacin Gemifloxacin Etodolac may increase the neuroexcitatory activities of Gemifloxacin.
Progesterone Progesterone The metabolism of Etodolac can be decreased when combined with Progesterone.
Infliximab Injection Infliximab Injection The metabolism of Etodolac can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Etodolac can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Etodolac.
Duloxetine Duloxetine The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Etodolac.
Tinidazole Tinidazole Etodolac may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The therapeutic efficacy of Bosentan can be decreased when used in combination with Etodolac.
Cefditoren Cefditoren Etodolac may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Etodolac may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Eszopiclone Eszopiclone Etodolac may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir Etodolac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Etodolac may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of hypertension can be increased when Etodolac is combined with Solifenacin.
Valganciclovir Valganciclovir Etodolac may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Etodolac can be decreased when combined with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Zoledronic acid.
Adefovir Adefovir Adefovir may decrease the excretion rate of Etodolac which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Etodolac may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Etodolac can be increased when combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Ibandronate.
Isocarboxazid Isocarboxazid The risk or severity of hypertension can be increased when Etodolac is combined with Isocarboxazid.
Ramelteon Ramelteon Etodolac may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Etodolac may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin Etodolac may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Deferasirox Deferasirox The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Etodolac is combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Etodolac.
Felbamate Felbamate The metabolism of Etodolac can be decreased when combined with Felbamate.
Ranolazine Ranolazine Etodolac may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Etodolac can be increased when combined with Abatacept.
Rasagiline Rasagiline Etodolac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The metabolism of Etodolac can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin Etodolac may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Etodolac may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Etodolac can be decreased when combined with Gefitinib.
Albuterol Albuterol Etodolac may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Etodolac may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Bortezomib Bortezomib The metabolism of Etodolac can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Etodolac may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Lubiprostone Lubiprostone Etodolac may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Aliskiren Aliskiren The risk or severity of renal failure and hypertension can be increased when Etodolac is combined with Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Etodolac.
Pemetrexed Injection Pemetrexed Injection Etodolac may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Lisdexamfetamine Lisdexamfetamine The risk or severity of hypertension can be increased when Etodolac is combined with Lisdexamfetamine.
Nabilone Nabilone The metabolism of Etodolac can be decreased when combined with Nabilone.
Sorafenib Sorafenib The metabolism of Etodolac can be decreased when combined with Sorafenib.
Dronabinol Dronabinol The metabolism of Etodolac can be decreased when combined with Dronabinol.
Levocetirizine Levocetirizine Etodolac may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Etodolac may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Armodafinil Armodafinil The metabolism of Etodolac can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Etodolac may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Lenalidomide Lenalidomide Etodolac may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Etodolac can be decreased when combined with Nilotinib.
Bexarotene Bexarotene The metabolism of Etodolac can be decreased when combined with Bexarotene.
Budesonide Budesonide The risk or severity of gastrointestinal irritation can be increased when Etodolac is combined with Budesonide.
Desmopressin Desmopressin The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etodolac is combined with Desmopressin.
Doripenem Injection Doripenem Injection Etodolac may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Etodolac can be decreased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Etodolac may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Etodolac.
Cevimeline Cevimeline Etodolac may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Nebivolol Nebivolol Etodolac may decrease the antihypertensive activities of Nebivolol.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Etodolac.
Flecainide Flecainide The metabolism of Etodolac can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Etodolac can be increased when combined with Certolizumab pegol.
Daptomycin Injection Daptomycin Injection Etodolac may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Etodolac may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Midazolam Midazolam Etodolac may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Etodolac may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Etodolac can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Etodolac.
Plerixafor Injection Plerixafor Injection Etodolac may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Etodolac.
Fesoterodine Fesoterodine Etodolac may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol Etodolac may decrease the antihypertensive activities of Betaxolol.
Iloperidone Iloperidone The risk or severity of hypertension can be increased when Etodolac is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Etodolac.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Etodolac may increase the excretion rate of Tolvaptan which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The risk or severity of hypertension can be increased when Etodolac is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Etodolac may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Etodolac may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Etodolac may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Etodolac may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Etodolac.
Topotecan Topotecan Etodolac may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Etodolac can be increased when combined with Golimumab.
Asenapine Asenapine The risk or severity of hypertension can be increased when Etodolac is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Etodolac.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Dabigatran.
Tocilizumab Injection Tocilizumab Injection The metabolism of Etodolac can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Etodolac may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Etodolac which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of hypertension can be increased when Etodolac is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The risk or severity of adverse effects can be increased when Acetaminophen is combined with Etodolac.
Vilazodone Vilazodone The risk or severity of hypertension can be increased when Etodolac is combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Etodolac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Etodolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Etodolac may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Azilsartan Azilsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Etodolac.
Roflumilast Roflumilast Etodolac may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Etodolac.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Etodolac can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Etodolac can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Ticagrelor.
Ruxolitinib Ruxolitinib Etodolac may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Etodolac may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib Vemurafenib The metabolism of Etodolac can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Etodolac can be decreased when combined with Vismodegib.
Deferiprone Deferiprone Etodolac may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Cabergoline Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Etodolac.
Naloxone Injection Naloxone Injection Etodolac may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Etodolac.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Fondaparinux.
Iloprost Iloprost The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Iloprost.
Enzalutamide Enzalutamide Etodolac may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron Etodolac may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Etodolac can be decreased when combined with Regorafenib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Etodolac.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Etodolac.
Teduglutide Injection Teduglutide Injection Etodolac may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Etodolac is combined with Icosapent ethyl.
Alogliptin Alogliptin Etodolac may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide Etodolac may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Apixaban.
Canagliflozin Canagliflozin Etodolac may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Etodolac can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Etodolac.
Trametinib Trametinib Etodolac may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Etodolac.
Ertapenem Injection Ertapenem Injection Etodolac may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Etodolac may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection The risk or severity of adverse effects can be increased when Ketorolac is combined with Etodolac.
Sofosbuvir Sofosbuvir Etodolac may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Etodolac may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast The metabolism of Etodolac can be increased when combined with Apremilast.
Droxidopa Droxidopa Etodolac may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Etodolac can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Etodolac can be increased when combined with Siltuximab.
Testosterone Injection Testosterone Injection Etodolac may decrease the excretion rate of Testosterone which could result in a higher serum level.
Oritavancin Injection Oritavancin Injection The metabolism of Etodolac can be decreased when combined with Oritavancin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Vorapaxar.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Edoxaban.
Methamphetamine Methamphetamine Etodolac may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Etodolac may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Riociguat Riociguat The therapeutic efficacy of Riociguat can be decreased when used in combination with Etodolac.
Secukinumab Injection Secukinumab Injection The metabolism of Etodolac can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of hypertension can be increased when Risperidone is combined with Etodolac.
Lenvatinib Lenvatinib The metabolism of Etodolac can be decreased when combined with Lenvatinib.
Haloperidol Injection Haloperidol Injection The therapeutic efficacy of Haloperidol can be increased when used in combination with Etodolac.
Amiloride Amiloride The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Amiloride.
Macitentan Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Etodolac.
Flibanserin Flibanserin The risk or severity of hypertension can be increased when Etodolac is combined with Flibanserin.
Prednisolone Prednisolone The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Etodolac.
Brexpiprazole Brexpiprazole The risk or severity of hypertension can be increased when Etodolac is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of hypertension can be increased when Ziprasidone is combined with Etodolac.
Cariprazine Cariprazine The risk or severity of hypertension can be increased when Etodolac is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Etodolac may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Etodolac.
Ixazomib Ixazomib Etodolac may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Etodolac may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Etodolac which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Etodolac.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection Etodolac may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Midodrine Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Etodolac.
Selexipag Selexipag The therapeutic efficacy of Selexipag can be decreased when used in combination with Etodolac.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Etodolac.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Etodolac.
Rucaparib Rucaparib The metabolism of Etodolac can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Etodolac may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Etodolac may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Etodolac may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Etodolac may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of gastrointestinal irritation can be increased when Deflazacort is combined with Etodolac.
Safinamide Safinamide The metabolism of Etodolac can be decreased when combined with Safinamide.
Edaravone Injection Edaravone Injection The excretion of Edaravone can be decreased when combined with Etodolac.
Naldemedine Naldemedine Etodolac may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Etodolac can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Etodolac can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Etodolac may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Etodolac may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Etodolac.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Etodolac.
Apalutamide Apalutamide Etodolac may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Avatrombopag Avatrombopag The metabolism of Etodolac can be increased when combined with Avatrombopag.
Baricitinib Baricitinib Etodolac may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Etodolac.
Plazomicin Injection Plazomicin Injection Etodolac may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Etodolac.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Etodolac.
Stiripentol Stiripentol Etodolac may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Rifamycin Rifamycin The metabolism of Etodolac can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Etodolac may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Etodolac can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Etodolac.
Acyclovir Ophthalmic Acyclovir Ophthalmic Etodolac may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Etodolac is combined with Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Etodolac.
Alpelisib Alpelisib The serum concentration of Etodolac can be decreased when it is combined with Alpelisib.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Etodolac.
Triclabendazole Triclabendazole The metabolism of Etodolac can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Etodolac.
Pitolisant Pitolisant The risk or severity of adverse effects can be increased when Etodolac is combined with Pitolisant.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Etodolac.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Etodolac.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Etodolac.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Etodolac.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Etodolac.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Etodolac is combined with Selpercatinib.
Pralsetinib Pralsetinib The metabolism of Etodolac can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Etodolac can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Etodolac is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Etodolac is combined with Drospirenone.
Viloxazine Viloxazine Etodolac may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Etodolac may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Fenoprofen Fenoprofen The risk or severity of adverse effects can be increased when Fenoprofen is combined with Etodolac.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Etodolac.
Mefenamic Acid Mefenamic Acid The risk or severity of adverse effects can be increased when Etodolac is combined with Mefenamic acid.
Naproxen Naproxen The risk or severity of adverse effects can be increased when Etodolac is combined with Naproxen.
Tolmetin Tolmetin The risk or severity of adverse effects can be increased when Tolmetin is combined with Etodolac.
Sulindac Sulindac The risk or severity of adverse effects can be increased when Sulindac is combined with Etodolac.
Trazodone Trazodone The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Etodolac.
Isotretinoin Isotretinoin Etodolac may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Etodolac may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine The metabolism of Etodolac can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Etodolac can be decreased when combined with Phenobarbital.
Metaxalone Metaxalone Etodolac may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The serum concentration of Methotrexate can be increased when it is combined with Etodolac.
Primidone Primidone The metabolism of Primidone can be decreased when combined with Etodolac.
Methsuximide Methsuximide The risk or severity of hyperkalemia can be increased when Etodolac is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of hypertension can be increased when Etodolac is combined with Diethylpropion.
Chlorpromazine Chlorpromazine Etodolac may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Etodolac may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Etodolac may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Etodolac may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Etodolac may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Etodolac may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Etodolac.
Carmustine Carmustine Etodolac may decrease the excretion rate of Carmustine which could result in a higher serum level.
Amantadine Amantadine Etodolac may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Etodolac may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of hypertension can be increased when Etodolac is combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Etodolac is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Etodolac can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Etodolac may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of hypertension can be increased when Etodolac is combined with Ergoloid mesylate.
Tetracycline Tetracycline Etodolac may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Thioridazine Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Etodolac.
Trifluoperazine Trifluoperazine The risk or severity of hypertension can be increased when Etodolac is combined with Trifluoperazine.
Bleomycin Bleomycin Etodolac may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Dapsone Dapsone The metabolism of Etodolac can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine Etodolac may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Methadone Methadone Etodolac may decrease the excretion rate of Methadone which could result in a higher serum level.
Benztropine Benztropine Etodolac may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Etodolac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline Maprotiline Etodolac may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen The risk or severity of adverse effects can be increased when Etodolac is combined with Ibuprofen.
Azathioprine Azathioprine Etodolac may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Phentermine Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Etodolac.
Methylphenidate Methylphenidate Etodolac may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of hypertension can be increased when Amoxapine is combined with Etodolac.
Sulfasalazine Sulfasalazine The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Etodolac.
Hydrocortisone Hydrocortisone The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Etodolac.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Etodolac is combined with Phenazopyridine.
Carbamazepine Carbamazepine Etodolac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Etodolac.
Clonidine Clonidine The therapeutic efficacy of Clonidine can be decreased when used in combination with Etodolac.
Prazosin Prazosin The therapeutic efficacy of Prazosin can be decreased when used in combination with Etodolac.
Hydralazine Hydralazine Etodolac may decrease the antihypertensive activities of Hydralazine.
Cimetidine Cimetidine Etodolac may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Etodolac may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Warfarin.
Clonazepam Clonazepam Etodolac may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of hyperkalemia can be increased when Etodolac is combined with Loperamide.
Promethazine Promethazine Etodolac may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate The risk or severity of adverse effects can be increased when Etodolac is combined with Meclofenamic acid.
Nitrofurantoin Nitrofurantoin Etodolac may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Etodolac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Etodolac may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The metabolism of Etodolac can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Etodolac.
Triamterene Triamterene The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Etodolac is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Etodolac.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Etodolac.
Metolazone Metolazone The therapeutic efficacy of Metolazone can be decreased when used in combination with Etodolac.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Etodolac may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine Etodolac may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Etodolac which could result in a higher serum level.
Imipramine Imipramine Imipramine may decrease the excretion rate of Etodolac which could result in a higher serum level.
Probenecid Probenecid Probenecid may decrease the excretion rate of Etodolac which could result in a higher serum level.
Quinidine Quinidine Etodolac may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Etodolac may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Etodolac may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Etodolac may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin The metabolism of Etodolac can be increased when combined with Rifampicin.
Disopyramide Disopyramide Etodolac may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Valproic Acid Valproic Acid The protein binding of Valproic acid can be decreased when combined with Etodolac.
Tamoxifen Tamoxifen The metabolism of Etodolac can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Etodolac may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Liothyronine Liothyronine Etodolac may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole Etodolac may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorpropamide Chlorpropamide The protein binding of Chlorpropamide can be decreased when combined with Etodolac.
Tolbutamide Tolbutamide The protein binding of Tolbutamide can be decreased when combined with Etodolac.
Tolazamide Tolazamide The protein binding of Tolazamide can be decreased when combined with Etodolac.
Dextromethorphan Dextromethorphan The metabolism of Etodolac can be decreased when combined with Dextromethorphan.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Etodolac.
Baclofen Baclofen Etodolac may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Etodolac may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Etodolac.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etodolac.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Etodolac is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone Etodolac may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Etodolac may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Etodolac may decrease the excretion rate of Folic acid which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Etodolac may decrease the antihypertensive activities of Propranolol.
Minoxidil Minoxidil The therapeutic efficacy of Minoxidil can be decreased when used in combination with Etodolac.
Pseudoephedrine Pseudoephedrine The risk or severity of hypertension can be increased when Etodolac is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The risk or severity of hypertension can be increased when Nortriptyline is combined with Etodolac.
Spironolactone Spironolactone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Etodolac which could result in a higher serum level.
Phytonadione Phytonadione Etodolac may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Etodolac may decrease the excretion rate of Amikacin which could result in a higher serum level.
Nadolol Nadolol Etodolac may decrease the antihypertensive activities of Nadolol.
Cholestyramine Resin Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Etodolac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol Allopurinol Etodolac may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Flavoxate Flavoxate Etodolac may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The metabolism of Etodolac can be decreased when combined with Fluorouracil.
Colchicine Colchicine Etodolac may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Etodolac may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cefadroxil Cefadroxil Etodolac may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Etodolac which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Etodolac which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Etodolac which could result in a higher serum level.
Dacarbazine Dacarbazine Etodolac may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Etodolac which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Etodolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Etodolac can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Etodolac may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Captopril Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Etodolac is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Etodolac.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Etodolac which could result in a higher serum level.
Metoprolol Metoprolol Etodolac may decrease the antihypertensive activities of Metoprolol.
Aspirin Aspirin The risk or severity of adverse effects can be increased when Etodolac is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of adverse effects can be increased when Etodolac is combined with Salsalate.
Alprazolam Alprazolam Etodolac may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Etodolac may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Etodolac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Etodolac may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Etodolac may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Etodolac may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Diltiazem Diltiazem The therapeutic efficacy of Diltiazem can be decreased when used in combination with Etodolac.
Nifedipine Nifedipine Etodolac may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol Timolol Etodolac may decrease the antihypertensive activities of Timolol.
Verapamil Verapamil Etodolac may decrease the excretion rate of Verapamil which could result in a higher serum level.
Atenolol Atenolol Etodolac may decrease the antihypertensive activities of Atenolol.
Pindolol Pindolol Etodolac may decrease the antihypertensive activities of Pindolol.
Cisplatin Injection Cisplatin Injection Etodolac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The therapeutic efficacy of Diflunisal can be decreased when used in combination with Etodolac.
Piroxicam Piroxicam The risk or severity of adverse effects can be increased when Piroxicam is combined with Etodolac.
Bumetanide Bumetanide The therapeutic efficacy of Bumetanide can be decreased when used in combination with Etodolac.
Glyburide Glyburide The protein binding of Glyburide can be decreased when combined with Etodolac.
Glipizide Glipizide The protein binding of Glipizide can be decreased when combined with Etodolac.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be decreased when used in combination with Etodolac.
Amoxicillin Amoxicillin Etodolac may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Etodolac may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Etodolac is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Etodolac which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Etodolac may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
Labetalol Labetalol Etodolac may decrease the antihypertensive activities of Labetalol.
Auranofin Auranofin Etodolac may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Etodolac may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Etodolac can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Etodolac.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Etodolac which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Etodolac which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of adverse effects can be increased when Etodolac is combined with Ketoprofen.
Cefotetan Injection Cefotetan Injection Etodolac may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Enalapril Enalapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etodolac.
Amiodarone Amiodarone The metabolism of Etodolac can be decreased when combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Etodolac may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Etodolac may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The metabolism of Etodolac can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin Etodolac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The therapeutic efficacy of Mesalazine can be decreased when used in combination with Etodolac.
Diclofenac Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Etodolac.
Fluoxetine Fluoxetine The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Etodolac.
Nimodipine Nimodipine The therapeutic efficacy of Nimodipine can be decreased when used in combination with Etodolac.
Clozapine Clozapine Etodolac may decrease the excretion rate of Clozapine which could result in a higher serum level.
Estazolam Estazolam Etodolac may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Etodolac.
Ofloxacin Ofloxacin Etodolac may increase the neuroexcitatory activities of Ofloxacin.
Didanosine Didanosine Etodolac may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Etodolac may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Benazepril.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Etodolac.
Fosinopril Fosinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Fosinopril.
Nabumetone Nabumetone The risk or severity of adverse effects can be increased when Nabumetone is combined with Etodolac.
Quinapril Quinapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Quinapril.
Ramipril Ramipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Ramipril.
Simvastatin Simvastatin The metabolism of Etodolac can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Etodolac may decrease the antihypertensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Etodolac can be decreased when combined with Teniposide.
Itraconazole Itraconazole The risk or severity of hyperkalemia can be increased when Etodolac is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Lisinopril.
Oxaprozin Oxaprozin The risk or severity of adverse effects can be increased when Etodolac is combined with Oxaprozin.
Atovaquone Atovaquone The metabolism of Etodolac can be decreased when combined with Atovaquone.
Sotalol Sotalol Etodolac may decrease the antihypertensive activities of Sotalol.
Bisoprolol Bisoprolol Etodolac may decrease the antihypertensive activities of Bisoprolol.
Zolpidem Zolpidem The metabolism of Etodolac can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The therapeutic efficacy of Doxazosin can be decreased when used in combination with Etodolac.
Terazosin Terazosin The therapeutic efficacy of Terazosin can be decreased when used in combination with Etodolac.
Isradipine Isradipine The therapeutic efficacy of Isradipine can be decreased when used in combination with Etodolac.
Omeprazole Omeprazole The metabolism of Etodolac can be decreased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Etodolac can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Etodolac can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine Venlafaxine may increase the antiplatelet activities of Etodolac.
Stavudine Stavudine The excretion of Stavudine can be decreased when combined with Etodolac.
Fluvoxamine Fluvoxamine The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Fluvoxamine.
Nefazodone Nefazodone The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Nefazodone.
Lamotrigine Lamotrigine Etodolac may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Losartan Losartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Etodolac.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Etodolac which could result in a higher serum level.
Tramadol Tramadol Etodolac may decrease the excretion rate of Tramadol which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Etodolac may decrease the excretion rate of Carboplatin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Etodolac can be decreased when combined with Lansoprazole.
Alprostadil Urogenital Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Etodolac.
Ifosfamide Injection Ifosfamide Injection Etodolac may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine Nicardipine The metabolism of Etodolac can be decreased when combined with Nicardipine.
Bupropion Bupropion Etodolac may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The risk or severity of bleeding can be increased when Etodolac is combined with Ticlopidine.
Metformin Metformin Etodolac may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Dalteparin.
Nisoldipine Nisoldipine The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Etodolac.
Lamivudine Lamivudine Etodolac may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Etodolac may decrease the excretion rate of Acarbose which could result in a higher serum level.
Glimepiride Glimepiride The protein binding of Glimepiride can be decreased when combined with Etodolac.
Gemcitabine Injection Gemcitabine Injection Etodolac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ritonavir Ritonavir The metabolism of Etodolac can be increased when combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Etodolac which could result in a higher serum level.
Meropenem Injection Meropenem Injection Etodolac may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine Etodolac may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Zafirlukast Zafirlukast The metabolism of Etodolac can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Etodolac may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Etodolac.
Trandolapril Trandolapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Trandolapril.
Topiramate Topiramate Etodolac may decrease the excretion rate of Topiramate which could result in a higher serum level.
Zileuton Zileuton The metabolism of Etodolac can be decreased when combined with Zileuton.
Valsartan Valsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Etodolac.
Pramipexole Pramipexole Etodolac may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Etodolac.
Nelfinavir Nelfinavir The metabolism of Etodolac can be decreased when combined with Nelfinavir.
Carvedilol Carvedilol Etodolac may decrease the antihypertensive activities of Carvedilol.
Nilutamide Nilutamide Etodolac may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Etodolac may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Etodolac.
Bicalutamide Bicalutamide The metabolism of Etodolac can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Etodolac.
Propafenone Propafenone Etodolac may decrease the antihypertensive activities of Propafenone.
Irbesartan Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Etodolac.
Tamsulosin Tamsulosin Etodolac may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Finasteride Finasteride The risk or severity of hypertension can be increased when Etodolac is combined with Finasteride.
Quetiapine Quetiapine Etodolac may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Etodolac which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Etodolac which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Etodolac which could result in a higher serum level.
Cetirizine Cetirizine Etodolac may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Etodolac.
Tolcapone Tolcapone Etodolac may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Etodolac.
Capecitabine Capecitabine The metabolism of Etodolac can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Etodolac can be decreased when combined with Efavirenz.
Abacavir Abacavir Etodolac may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Etodolac can be decreased when combined with Sildenafil.
Celecoxib Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Etodolac.
Rosiglitazone Rosiglitazone Etodolac may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine Etodolac may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The metabolism of Thalidomide can be decreased when combined with Etodolac.
Oseltamivir Oseltamivir Etodolac may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Etodolac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide The therapeutic efficacy of Balsalazide can be decreased when used in combination with Etodolac.
Nateglinide Nateglinide Etodolac may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Etodolac may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Etodolac.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists